Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agents

Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agents Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors Synthesis and anticancer activities of thieno[3,2-d]pyrimidines as novel HDAC inhibitors Development of hydroxamate-based histone deacetylase inhibitors containing 1,2,4-oxadiazole moiety core with antitumor activities Design, synthesis, and preliminary bioactivity studies of substituted purine hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors Design, synthesis and activity evaluation of indole-based double – Branched HDAC1 inhibitors Design and synthesis of a new generation of substituted purine hydroxamate analogs as histone deacetylase inhibitors The design, synthesis and structure–activity relationships of novel isoindoline-based histone deacetylase inhibitors Design, synthesis, and biological evaluation of indole-based hydroxamic acid derivatives as histone deacetylase inhibitors Selective HDAC inhibitors with potent oral activity against leukemia and colorectal cancer: Design, structure-activity relationship and anti-tumor activity study